We built the most advanced and robust testing anywhere in the world, and we’ve done more testing than any country anywhere in the world.
-President Donald J. Trump
PROVIDING TESTING RESOURCES: President Donald J. Trump is working tirelessly to ensure that every State, territory, and tribe has the resources they need to meet their testing goals.
- The Administration is sending $11 billion to help States, territories, and tribes meet the testing goals set out by their Governors and tribal leaders.
- The Federal Government will be sending approximately 12 million swabs to States over the course of May to supplement private sector resources.
- President Donald J. Trump is also working to ensure manufacturers are producing enough testing supplies – such as reagents and extraction kits – to support our robust testing system.
- The Administration has partnered with leading retail companies as well as local independent pharmacies to increase access to testing for Americans in more communities.
- By the end of this week, more than 300 retail testing sites will be operational to serve Americans in 47 states and D.C., prioritizing access in underserved communities.
- President Trump revolutionized our testing system and, in partnership with Governors, scaled up testing across the country to unprecedented levels.
- More than 9 million tests have now been completed in the United States – by far the most in the world – and this number will soon surpass 10 million.
- Last week, as many as 314,000 Americans were tested a day.
- The United States is testing more than every country on Earth, including South Korea, Japan, the United Kingdom, and Italy.
- In May, every single State will be able to test more people per capita than South Korea has tested per capita in four months since the outbreak began.
- The Trump Administration is leveraging the power of the private sector to accelerate research and development of innovative diagnostic tests.
- Already, the Food and Drug Administration (FDA) has granted 92 emergency use authorizations for coronavirus tests – more authorizations than for H1N1, Avian flu, MERS, Ebola, Enterovirus, and Zika combined.
- The FDA’s quick authorization of tests created by companies such as Roche, LabCorp, Abbott Labs, and many others have greatly increased America’s testing speed and capacity.
- These efforts have allowed Americans to receive testing results in as little as five minutes, or collect a sample for a test within the comfort of their own homes.
- New antibody tests, antigen tests, point-of-care nucleic acid testing, and genomic sequencing technologies are under development, which will enhance our coronavirus monitoring efforts.